EyePoint EYPT
NASDAQ EYPT
$3.34 -0.09 (-2.49%)
As of: Sep 30, 2026 · 10:25 AM EDT

EyePoint (EYPT) EV to EBITDA (2014 - 2015)

Updated

EyePoint's (EYPT) EV to EBITDA stood at 11.28 in Q4 2015, up 13.4% from the prior quarter.

Analysis

EyePoint (EYPT) EV to EBITDA (2014 - 2015) Analysis & Trends

Starting with Q1 2015, EyePoint's EV to EBITDA history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 9.94 (Q3 2015), 7.51 (Q2 2015) and 9.67 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 EyePoint 281.29 Mn -631.84 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 11.28
Mar 31, 2015 9.94
Dec 31, 2014 7.51
Sep 30, 2014 9.67
API Access

EyePoint EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=EYPT&period=max&api_key=YOUR_API_KEY